Try our beta test site
669 studies found for:    Studies With Results | lymphoma OR CLL
Show Display Options
Rank Status Study
1 Completed
Has Results
Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase: Phase 2
Number Enrolled: 33
Study Start: February 2007
Study Completion: November 2010
2 Completed
Has Results
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
Phase: Phase 2
Number Enrolled: 145
Study Start: January 2013
Study Completion: April 2016
3 Terminated
Has Results
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Phase: Phase 2
Number Enrolled: 10
Study Start: July 2010
Study Completion: January 2015
4 Terminated
Has Results
Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Phase: Phase 2
Number Enrolled: 6
Study Start: January 2009
Study Completion: July 2014
5 Completed
Has Results
A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2)
Phase: Phase 3
Number Enrolled: 269
Study Start: March 2013
Study Completion: May 2015
6 Completed
Has Results
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase 2
Number Enrolled: 77
Study Start: July 2010
Study Completion: August 2016
7 Completed
Has Results
Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase: Phase 2
Number Enrolled: 16
Study Start: August 2009
Study Completion: April 2013
8 Completed
Has Results
Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL)
Phase: Phase 2
Number Enrolled: 21
Study Start: August 2010
Study Completion: August 2012
9 Terminated
Has Results
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
Phase: Phase 2
Number Enrolled: 2
Study Start: March 2006
Study Completion: January 2010
10 Completed
Has Results
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia
Phase: Phase 3
Number Enrolled: 90
Study Start: March 2012
Study Completion:
11 Completed
Has Results
Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase 2
Number Enrolled: 18
Study Start: August 2007
Study Completion: January 2011
12 Completed
Has Results
Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis
Phase: Phase 2
Number Enrolled: 105
Study Start: September 1997
Study Completion: November 2011
13 Completed
Has Results
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
Phase: Phase 1
Number Enrolled: 33
Study Start: February 2011
Study Completion: May 2013
14 Terminated
Has Results
Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
Phase: Phase 2
Number Enrolled: 1
Study Start: March 2010
Study Completion: March 2011
15 Completed
Has Results
Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase 2
Number Enrolled: 41
Study Start: July 2008
Study Completion: May 2014
16 Completed
Has Results
Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)
Phases: Phase 1 / Phase 2
Number Enrolled: 12
Study Start: January 2007
Study Completion: June 2009
17 Active, not recruiting
Has Results
A Study of PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma
Phase: Phase 3
Number Enrolled: 160
Study Start: October 2013
Study Completion: June 2017
18 Completed
Has Results
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phases: Phase 1 / Phase 2
Number Enrolled: 15
Study Start: September 2011
Study Completion: February 2014
19 Terminated
Has Results
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Phase: Phase 1
Number Enrolled: 3
Study Start: September 2000
Study Completion:
20 Active, not recruiting
Has Results
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase 2
Number Enrolled: 45
Study Start: February 2008
Study Completion: December 2016

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.